ANI Pharmaceuticals, Inc.

Contributing Author

Recent Articles by ANI Pharmaceuticals, Inc.

9 hours	ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET ANIP GlobeNewswire
Apr-20	ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity ANIP GlobeNewswire
Apr-13	ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules ANIP GlobeNewswire
Apr-08	ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet ANIP GlobeNewswire
Apr-07	ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology ANIP GlobeNewswire
Feb-27	ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance ANIP GlobeNewswire
Feb-24	ANI Pharmaceuticals to Present at Upcoming Investor Conferences ANIP GlobeNewswire
Feb-13	ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET ANIP GlobeNewswire
Jan-12	ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities ANIP +10.58% GlobeNewswire
Jan-06	ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference ANIP GlobeNewswire
Dec-02	ANI Pharmaceuticals Announces Formation of "FutureVision Advisory Council" to Help Strategically Guide Ophthalmology and Retina Franchise ANIP GlobeNewswire
Dec-01	ANI Pharmaceuticals Announces Board Transition ANIP GlobeNewswire
Nov-25	ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference ANIP GlobeNewswire
Nov-11	ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - London ANIP GlobeNewswire
Nov-07	ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance ANIP GlobeNewswire
Oct-24	ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET ANIP GlobeNewswire
Oct-16	ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting ANIP GlobeNewswire
Aug-25	ANI Pharmaceuticals to Present at Upcoming Investor Conferences ANIP GlobeNewswire
Aug-08	ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance ANIP +18.07% GlobeNewswire
Aug-01	ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET ANIP GlobeNewswire
Jul-23	ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN for Use in Patients with Diabetic Macular Edema (DME) ANIP GlobeNewswire
Jul-02	ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th ANIP GlobeNewswire
Jun-12	ANI Pharmaceuticals Announces Presentation of New Preclinical Data ANIP GlobeNewswire
May-27	ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference ANIP GlobeNewswire
May-22	ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin Gel for the Treatment of Acute Gout Flares ANIP GlobeNewswire
May-12	ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ ANIP -6.03% GlobeNewswire
May-09	ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance ANIP -7.31% GlobeNewswire
May-05	ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model ANIP GlobeNewswire

ANI Pharmaceuticals, Inc.

Recent Articles by ANI Pharmaceuticals, Inc.

Upgrade your Finviz experience